Cytokines in cancer pathogenesis and cancer therapy

被引：1180

作者：

Dranoff, G ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

NATURE REVIEWS CANCER | 2004年 / 4卷 / 01期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrc1252

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The mixture of cytokines that is produced in the tumour microenvironment has an important role in cancer pathogenesis. Cytokines that are released in response to infection, inflammation and immunity can function to inhibit tumour development and progression. Alternatively, cancer cells can respond to host-derived cytokines that promote growth, attenuate apoptosis and facilitate invasion and metastasis. A more detailed understanding of cytokine-tumour-cell interactions provides new opportunities for improving cancer immunotherapy.

引用

页码：11 / 22

页数：12

共 138 条

[1] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].

Albert, ML ;

Pearce, SFA ;

Francisco, LM ;

Sauter, B ;

Roy, P ;

Silverstein, RL ;

Bhardwaj, N .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368

[2] THE CAUSES AND PREVENTION OF CANCER [J].

AMES, BN ;

GOLD, LS ;

WILLETT, WC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5258-5265

[3]

Anderson PM, 1999, CLIN CANCER RES, V5, P2316

[4]

Atkins MB, 1997, CLIN CANCER RES, V3, P409

[5] The IFN gamma receptor: A paradigm for cytokine receptor signaling [J].

Bach, EA ;

Aguet, M ;

Schreiber, RD .

ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :563-&

[6] Dendritic cells and the control of immunity [J].

Banchereau, J ;

Steinman, RM .

NATURE, 1998, 392 (6673) :245-252

[7] CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin [J].

Basu, S ;

Binder, RJ ;

Ramalingam, T ;

Srivastava, PK .

IMMUNITY, 2001, 14 (03) :303-313

[8] Interferons α and β as immune regulators -: A new look [J].

Biron, CA .

IMMUNITY, 2001, 14 (06) :661-664

[9] Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice [J].

Boggio, K ;

Nicoletti, G ;

Di Carlo, E ;

Cavallo, F ;

Landuzzi, L ;

Melani, C ;

Giovarelli, M ;

Rossi, I ;

Nanni, P ;

De Giovanni, C ;

Bouchard, P ;

Wolf, S ;

Modesti, A ;

Musiani, P ;

Lollini, PL ;

Colombo, MP ;

Forni, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) :589-596

[10] Human tumor antigens recognized by T lymphocytes [J].

Boon, T ;

vanderBruggen, P .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :725-729

← 1 2 3 4 5 6 7 8 9 10 →